KAREN KASARDA: Open Payments
NPI 1700991965 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 29 payments from 9 companies in 2025. Trend: 2023 $644 · 2024 $377 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $192 |
| Novo Nordisk Inc | 7 | $162 |
| GlaxoSmithKline, LLC. | 3 | $150 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
| Viatris Specialty LLC | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: AREXVY, QULIPTA, Ozempic, UBRELVY, Rybelsus, VOQUEZNA, TZIELD, SHINGRIX.
Industry payments across NY — which companies pay providers there.
